Status:
COMPLETED
Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound
Lead Sponsor:
Ma Zhe
Conditions:
Breast Diseases
Eligibility:
FEMALE
15-80 years
Brief Summary
This retrospective study aimed to create a prediction model using deep learning and radiomics features extracted from intratumoral and peritumoral regions of breast lesions in ultrasound images, to di...
Eligibility Criteria
Inclusion
- female patients with US-visible solid breast masses who underwent biopsy and/or surgical resection, and were classified as having BI-RADS 4 lesions in medical US reports.
Exclusion
- preoperative endocrine therapy, chemotherapy, or radiotherapy, preoperative invasive breast operation, insufficient image quality, and no pathological results.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06069921
Start Date
January 1 2015
End Date
December 30 2022
Last Update
June 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QianfoshanH
Jinan, Shandong, China, 250014